052sek
-0,8 %
Date:2024-04-30Time:12:59:00Latest report:Q4-2023List:First NorthTicker:TOL
Market Cap:102 msekEnterprise Value:84 msekNet Sales:- msekEarnings:-7,46 msekEmployees:0ISIN:SE0007438577

Ratios

10-year key figure history for Toleranzia turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Toleranzia with index and moving average MA50 and MA200.

Stockprice:0,52
MA50:0,48
MA200:0,51
Price/MA200:2,3 %
RSI (14):54,9
Price/MA50:6,9 %

Description

Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.

Medical Equipment